A Pittsburgh study to detemine whether the use of whole genome sequencing (WGS) provides a faster genetic diagnosis for infants in the intensive care unit (ICU) population compared to standard-of-care testing is underway within the UPMC health system. In the study, known as PISCES, researchers will examine whether early diagnosis through WGS can lead to better outcomes and reduced costs of medical care. Critically ill infants in the ICU’s at UPMC Magee Womens Hospital and UPMC Children’s Hosptial of Pittsburgh are eligible for enrollment in this study with WGS being performed at the UPMC Genome Center.
Further study details and information on eligibility criteria can be found here.
The sequencing study is supported by the R.K. Mellon Foundation using funds provided to the Institute for Precision Medicine as previously announced.